To curb the spread of Covid-19 in regions, currently 147 regencies/cities are aggressively conducting Covid-19 tests above the national average. Data as of Monday, November 7, 2022, shows the national average testing rate at 0.42 people per 1000 population/week.
The top five, starting from the highest number of people tested per 1000 population/week, are Central Jakarta City (5.21 people), South Jakarta City (5.21 people), Balikpapan City (4.67 people), West Jakarta City (3.58 people), and East Jakarta City (3.54 people).
Central Jakarta City ranks first. With a population of 913,720, the number of people tested here is recorded at 5.21 per 1000 population/week. The latest positive rate is 23.74 percent. The positive rate in this region increased compared to the previous week's ratio.
Next is South Jakarta City. In an effort to combat the Covid-19 pandemic, the number of people tested is 5.21 per 1000 population/week. The positive rate in this region is 20.47 percent, also higher than the previous week's ratio.
Furthermore, Covid-19 testing in Balikpapan City recorded 4.67 people per 1000 population/week, 3.58 people per 1000 population/week in West Jakarta City, and 3.54 people per 1000 population/week in East Jakarta City.
Anticipating the impact of Omicron in various regions, based on the national Covid data recapitulation, there are 143 regencies/cities in Indonesia actively reporting a higher daily number of people tested than before. Meanwhile, 138 other regencies/cities recorded a lower number of people tested compared to the previous week.
Regions outside Java with the highest number of people tested include Balikpapan City, Badung, and Mimika, with 4.67, 2.63, and 2.31 people tested, respectively.
Although Covid-19 transmission has decreased in some areas, the government urges everyone to continue reducing Covid-19 transmission by always wearing masks, maintaining distance, and frequently washing hands with soap and running water. Avoiding crowds and reducing mobility also contribute to curbing the spread of the coronavirus.